Sangamo Therapeutics Ownership | Who Owns Sangamo Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Sangamo Therapeutics Ownership Summary


Sangamo Therapeutics is owned by 23.76% institutional investors, 2.81% insiders, and 73.43% retail investors. Vanguard group is the largest institutional shareholder, holding 4.50% of SGMO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.61% of its assets in Sangamo Therapeutics shares.

SGMO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSangamo Therapeutics23.76%2.81%73.43%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group9.37M4.50%$9.56M
Wasatch advisors lp9.23M4.43%$9.42M
Blackrock4.70M2.61%$1.69M
Blackrock funding, inc. /de5.19M2.49%$5.30M
Jacobs levy equity management2.95M1.64%$1.06M
Renaissance3.08M1.48%$3.15M
Millennium management2.74M1.31%$2.79M
Point72 asset management2.27M1.09%$2.32M
Geode capital management2.21M1.06%$2.26M
Ikarian capital1.86M0.89%$1.90M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ikarian capital1.86M0.26%$1.90M
Golden state equity partners325.68K0.06%$332.20K
Wasatch advisors lp9.23M0.05%$9.42M
Shelton wealth management28.00K0.01%$28.56K
Point72 asia (singapore) pte.51.20K0.01%$52.22K
Boothbay fund management537.22K0.01%$547.96K
Schonfeld strategic advisors1.71M0.01%$1.74M
Founders capital management14.00K0.01%$14.28K
Sandbox financial partners24.83K0.01%$25.33K
Point72 asset management2.27M0.01%$2.32M

Top Buyers

HolderShares% AssetsChange
Jacobs levy equity management2.95M0.00%2.76M
Point72 asset management2.27M0.01%2.27M
Ikarian capital1.86M0.26%1.86M
Schonfeld strategic advisors1.71M0.01%1.71M
Blackrock funding, inc. /de5.19M0.00%1.56M

Top Sellers

HolderShares% AssetsChange
Armistice capital---14.06M
Wasatch advisors lp9.23M0.05%-10.21M
Blackrock4.70M--8.57M
Acadian asset management---4.56M
State street519.22K--2.23M

New Positions

HolderShares% AssetsChangeValue
Point72 asset management2.27M0.01%2.27M$2.32M
Ikarian capital1.86M0.26%1.86M$1.90M
Squarepoint ops710.36K0.00%710.36K$724.57K
Boothbay fund management537.22K0.01%537.22K$547.96K
Mitsubishi ufj kokusai asset management124.04K0.00%124.04K$161.25K

Sold Out

HolderChange
Headlands-5.00
Td waterhouse canada-31.00
Gps wealth strategies group-100.00
Srs capital advisors-142.00
Kohmann bosshard financial services-155.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025130-4.41%52,338,132-14.91%232.73%55-22.54%349.68%
Dec 31, 202413218.92%56,338,8180.73%273.75%6763.41%31-6.06%
Sep 30, 2024111-13.28%55,928,091-35.58%261.16%41-28.07%33-23.26%
Jun 30, 2024128-3.03%86,818,721-14.00%481.54%577.55%43-12.24%
Mar 31, 20241320.76%100,948,72016.17%552.34%53-13.11%4913.95%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv5.99M2.61%-
Vanguard US Total Market Shares ETF5.65M2.51%1.00
Wasatch Ultra Growth4.53M2.02%-
SPDR® S&P Biotech ETF3.73M1.75%-22.75K
Vanguard Institutional Extnd Mkt Idx Tr3.07M1.34%-
Wasatch Micro Cap2.34M1.12%-3.31M
Vanguard Strategic Small-Cap Equity Inv1.71M0.82%-
Vanguard Explorer Inv1.40M0.67%-
Fidelity Extended Market Index1.06M0.47%27.64K
Schwab US Small-Cap ETF™898.50K0.37%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 26, 2023BIOGEN INC.-Sell$3.00M
Aug 29, 2022BIOGEN INC.-Sell$2.13M
Aug 30, 2022BIOGEN INC.-Sell$526.52K
Aug 29, 2022Biogen MA Inc. Sell$526.52K
Aug 29, 2022Biogen MA Inc. Sell$2.13M

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q2--

SGMO Ownership FAQ


Who Owns Sangamo Therapeutics?

Sangamo Therapeutics shareholders are primarily institutional investors at 23.76%, followed by 2.81% insiders and 73.43% retail investors. The average institutional ownership in Sangamo Therapeutics's industry, Biotech Stocks , is 63.96%, which Sangamo Therapeutics falls below.

Who owns the most shares of Sangamo Therapeutics?

Sangamo Therapeutics’s largest shareholders are Vanguard group (9.37M shares, 4.50%), Wasatch advisors lp (9.23M shares, 4.43%), and Blackrock (4.7M shares, 2.61%). Together, they hold 11.54% of Sangamo Therapeutics’s total shares outstanding.

Does Blackrock own Sangamo Therapeutics?

Yes, BlackRock owns 2.61% of Sangamo Therapeutics, totaling 4.7M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.69M$. In the last quarter, BlackRock decreased its holdings by -8.575M shares, a -64.58% change.

Who is Sangamo Therapeutics’s biggest shareholder by percentage of total assets invested?

Ikarian capital is Sangamo Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.26% of its assets in 1.86M Sangamo Therapeutics shares, valued at 1.9M$.

Who is the top mutual fund holder of Sangamo Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Sangamo Therapeutics shares, with 2.61% of its total shares outstanding invested in 5.99M Sangamo Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools